A&G Pharmaceutical Inc.
1 clinical trials · Sponsor
◉ Watch A&G Pharmaceutical Inc.
| Record | Firm | Date |
|---|---|---|
| First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies (NCT05627960) | A&G Pharmaceutical Inc. | 2022-02-14 |
Track A&G Pharmaceutical Inc. automatically
Every clearance here is in the API, with alerts when new ones post.